Global Intrauterine Devices Market Overview:
Intrauterine Devices are generally T-shaped devices that are used for birth control measures. These devices are inserted into the uterus to prevent pregnancy. Intrauterine Devices are one of the greatest satisfactions providing methods birth control measures. Intrauterine Devices reduce pregnancy risks to less than 1%. Since they last between three and ten years, intrauterine devices are one of the most convenient means of birth control. Some of their biggest advantages are they provide convenience, and they are very inexpensive. As the need for family planning increases the demand for Intrauterine Devices increases.
- Need of Family Planning
- Demand for Long-Term Birth Control Measures
- Growing Innovation in Hormonal Intrauterine Devices
- Intrauterine Devices Do Not Protect Against STDs
- Growing Awareness About Family Planning Will Increase the Demand of Intrauterine Devices
- Increasing Demand of Intrauterine Devices from Large Population Countries Like China and India
- As Intrauterine Devices Are Long Term Measures, Repeated Demand Is Not Possible
- Intrauterine Devices May Make Periods Irregular
There are a limited number of players as strict regulations were necessary for the manufacture of Intrauterine Devices. These regulations may act as a barrier to entry into this market. Players in this market have to comply with the regulations of each country or region if they desire to sell their product in that region or the country. As the world population increases drastically; the demand for Intrauterine Devices is also going to increase.
Some of the key players profiled in the report are CooperSurgical, Inc. (United States), DKT International (United States), Melbea AG (Hungary), Pregna International Limited (India), Ocon Medical Ltd (Israel), SMB Corporation of India (India), Mona Lisa N.V. (Belgium), Bayer AG (Germany), Erenler Medikal (Turkey) and Gyneas (France). Considering Market by Sales Channel, the sub-segment i.e. Direct will boost the Intrauterine Devices market. Considering Market by Age Group, the sub-segment i.e. Age 20-24 will boost the Intrauterine Devices market.
In Aug 2020, FDA extended the use of Mirana, an intrauterine system up to 6 years for pregnancy prevention. By the previous indication, it was only up to 5 years. Mirana is a hormonal intrauterine device that is classified as a long-term reversible contraceptive method. It has T shape structure.
What Can be Explored with the Intrauterine Devices Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Intrauterine Devices Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Intrauterine Devices
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Intrauterine Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Intrauterine Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Intrauterine Devices Manufacturers, Suppliers, and Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations, End-Use Industries and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.